The association between total antioxidant status and oxidative stress in Behçet's disease

Rheumatology International

Volumn 26, Issue 11, 2006, Pages 1005-1009

  Sepici Dinçel, Aylin ^a   Özkan, Yeşim ^a   Yardim Akaydin, Sevgi ^a   Kaymak Karataş, Gülçin ^a   Önder, Meltem ^a   Şimşek, Bolkan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Copper; Iron; Oxidative stress; Total antioxidant status

Indexed keywords

COLCHICINE; IRON;

ADULT; AGED; ANTIOXIDANT ACTIVITY; APHTHOUS STOMATITIS; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IRON BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; AGED; ANTIOXIDANTS; BEHCET SYNDROME; COPPER; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; OXIDATIVE STRESS; STOMATITIS, APHTHOUS;

EID: 33748710069     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0126-3     Document Type: Article

References (29)

1. Onder M, Gurer MA (2000) The multiple faces of Behçet's disease and its etiological factors. J Eur Acad Dermatol Venereol 15:126-136
2. Ghate JV, Jorizzo JL (2001) Behçet's disease Kelley's textbook of rheumatology. Saunders, Philadelphia, pp 1205-1209
3. Yurdakul S, Yazici H, Tuzun Y, Pazarli H, Yalcin B, Altac M, Ozyazgan Y, Tuzuner N, Muftuoglu A (1983) The arthritis of Behçet's disease: prospective study. Ann Rheum Dis 42:505-515
4. Kim HA, Choi KW, Song YW (1997) Arthropathy in Behçet's disease. Scand J Rheumatol 26:125-129
5. Benamour S, Zeroual B, Alaoui FZ (1998) Joint manifestations in Behçet's disease: a review of 340 cases. Rev Rhum Engl Ed 65:299-307
6. Porter SR, Hegarty A, Kaliakatsou F, Hodgson TA, Scully C (2000) Recurrent aphthous stomatitis. Clin Dermatol 18:569-578
7. Karincaoglu Y, Batcioglu K, Erdem T, Esrefoglu M, Genc M (2005) The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol Med 34:7-12
8. Onder M (2001) Oral aphthous. Medical education of dermatologist represented meeting, Greece, pp 35-39
9. Marshall Sara E (2004) Behçet's disease Best practice and research. Clin Rheumatol 18(3):291-311
10. Babior BM (2000) Phagocytes and oxidative stress. Am J Med 109:33-44
11. Iijima S, Otsuka F (1997) Peripheral blood neutrophil rheology measured by microspore filtration reflects Behçet's disease activity well. J Dermatol Sci 15:44-50
12. Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82:291-295
13. Serafini M, Del Rio D (2004) Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?. Redox Rep 9(3):145-152
14. Llesuy S, Evelson P, Campos AM, Lissi E (2001) Methodologies for evaluation of total antioxidant activities in complex mixtures A critical review. Biol Res 34(2):51-73
15. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
16. Verde V, Fogliano V, Ritieni A, Maiani G, Morisco F, Caporaso N (2002) Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma. Free Radic Res 36(8):869-873
17. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity, and its application to monitoring antioxidant status in premature neonates. Clin Sci 84:407-412
18. Henry RJ, Cannon D, Winkleman JW (eds) (1974) Clinical Chemistry principles and technica, 2nd edn, Harper and Row, London, pp 699-705
19. Halliwell B, Whiteman M (2004) Measuring RS and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 142:231-255
20. Dotan Y, Lichtenberg D, Pinchuk I (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43(3):200-227
21. Therond P, Bonnefont-Rousselot D, Davit-Spraul A, et al. (2000) Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 3:373-384
22. Kokcam I, Nazíroglu M (2002) Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet's disease. Clin Biochem 35(8):633-639
23. Yazici C, Kose K, Calis M, Demir M, Kirnap M, Ates F (2004) Increased advanced oxidation protein products in Behçet's disease: a new activity marker. Br J Dermatol 151(July):105
24. Bekpinar S, Kilic N, Unlucerci Y, Akdag-Kose A, Azizlerli G, Ozbek-Kir Z (2005) Evaluation of nitrosative and oxidative stress in Behcet disease. J Eur Acad Dermatol Venereol 19(2):167-171
25. Yardim-Akaydin S, Sepici A, Ozkan Y, Simsek B, Sepici V (2006) Evaluation of allantoin levels as a new marker of oxidative stress in Behcet's disease. Scand J Rheumatol 35(1):61-64
26. Matés JM (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species in toxicology. Toxicology 153:83-104
27. Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC (2001) Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol 21:1190-1195
28. Orem A, Yandi YE, Vanizor B, Cimsit G, Uydu HA, Malkoc M (2002) The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. Clin Chem 35:217-224
29. Pronai L, Ichikawa Y, Nakazawa H, Arimori S (1991) Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet's disease effects of colchicine. Clin Exp Rheumatol 9:227-233